This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Bupropion-Tranylcypromine Combination for Treatment-Refractory Depression

Joseph M. Pierre and Michael J. Gitlin

Published: November 30, 2000

Article Abstract

Letter to the Editor

Sir: We report the safe and successful use of combined bupropion
and tranylcypromine in a case of treatment-refractory
depression.

Case report. Ms. A, a 27-year-old woman with chronic major
depression (DSM-III-R criteria), was treated in 1990 at age
17 with imipramine up to 150 mg/day. In March 1994, after a
suicide attempt by imipramine overdose, paroxetine, 20 mg/day,
replaced imipramine. On paroxetine, 30 mg/day, and amitriptyline,
50 mg q.h.s., she experienced only mild improvement at
6 months.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500...

Read More...